• 1. Fe3O4@SiO2 core–shell nanoparticles for biomedical purposes: adverse effects on blood cells?
  C. Achilli,G. F. Guidetti,A. Ciana,D. Capsoni,G. Minetti Biomater. Sci., 2016,4, 1417-1421
• 2. Excited state characterization of carbonyl containing carotenoids: a comparison between single and multireference descriptions?
  Riccardo Spezia,Stefan Knecht,Benedetta Mennucci Phys. Chem. Chem. Phys., 2017,19, 17156-17166
• 3. Excimer emission and magnetoluminescence of radical-based zinc(ii) complexes doped in host crystals?
  Shojiro Kimura,Tetsuro Kusamoto Chem. Commun., 2020,56, 11195-11198
• 4. Fe3O4/PEG-SO3H as a heterogeneous and magnetically-recyclable nanocatalyst for the oxidation of sulfides to sulfones or sulfoxides
  Saeideh Mirfakhraei,Malak Hekmati,Fereshteh Hosseini Eshbala,Hojat Veisi New J. Chem., 2018,42, 1757-1761
• 5. Evolution of dealloying induced strain in nanoporous gold crystals?
  Ross Harder,David C. Dunand,Ian McNulty Nanoscale, 2017,9, 5686-5693

• Solvents and Organic Chemicals Organic Compounds Benzenoids Phenols Nitrophenols

Professional Introduction to 2,5-Difluoro-4-nitrophenol (CAS No 120103-18-6)

2,5-Difluoro-4-nitrophenol is a fluorinated nitroaromatic compound that has garnered significant attention in the field of chemical and pharmaceutical research due to its unique structural and functional properties. This compound, identified by the Chemical Abstracts Service Number (CAS No) 120103-18-6, represents a critical intermediate in the synthesis of various pharmacologically active molecules. Its molecular structure, characterized by the presence of both fluorine and nitro substituents on a phenolic ring, imparts distinct reactivity and potential applications in medicinal chemistry.

The significance of 2,5-Difluoro-4-nitrophenol lies in its versatility as a building block for more complex chemical entities. The fluorine atoms at the 2- and 5-positions enhance the compound's lipophilicity and metabolic stability, making it an attractive candidate for drug development. In contrast, the nitro group at the 4-position introduces electrophilic reactivity, facilitating further functionalization through reduction or nucleophilic substitution reactions. These features have made this compound a focal point in the design of novel therapeutic agents targeting various biological pathways.

Recent advancements in synthetic methodologies have further highlighted the utility of 2,5-Difluoro-4-nitrophenol. Researchers have demonstrated efficient synthetic routes to this compound, leveraging modern techniques such as transition-metal-catalyzed cross-coupling reactions and palladium-mediated transformations. These methods not only improve yield but also enhance scalability, making 2,5-Difluoro-4-nitrophenol more accessible for industrial applications. The ability to produce this intermediate in high purity and quantity underscores its importance in pharmaceutical manufacturing processes.

In the realm of medicinal chemistry, 2,5-Difluoro-4-nitrophenol has been explored as a precursor for a wide range of bioactive molecules. Its structural framework is well-suited for modulating enzyme activity and interacting with biological targets. For instance, derivatives of this compound have shown promise in inhibiting enzymes involved in inflammatory responses and cancer progression. The fluorine substituents play a crucial role in enhancing binding affinity by improving hydrophobic interactions with protein targets, while the nitro group can be further functionalized to introduce additional pharmacological properties.

The incorporation of fluorine into pharmaceuticals is a well-documented strategy to improve drug efficacy and pharmacokinetic profiles. Fluorinated aromatic compounds often exhibit increased metabolic stability, reduced susceptibility to degradation by enzymes, and enhanced cell membrane permeability. These attributes are particularly valuable in the development of small-molecule drugs that require prolonged circulation times or targeted delivery to specific tissues. The presence of both fluorine and nitro groups in 2,5-Difluoro-4-nitrophenol thus positions it as a versatile scaffold for designing next-generation therapeutics.

Current research endeavors are focused on expanding the chemical space accessible through derivatives of 2,5-Difluoro-4-nitrophenol. By employing structure-activity relationship (SAR) studies, scientists aim to optimize the pharmacological properties of these derivatives. Techniques such as high-throughput screening and computational modeling are being utilized to identify lead compounds with enhanced potency and selectivity. The goal is to develop novel treatments that address unmet medical needs while minimizing side effects.

The environmental impact of fluorinated compounds is also a consideration in their development and application. While fluorine offers numerous benefits in drug design, its persistence in the environment raises concerns about long-term ecological effects. Efforts are underway to balance pharmacological advantages with environmental responsibility by designing compounds that are both effective and biodegradable. This includes exploring alternative synthetic routes that reduce waste and minimize the use of hazardous reagents.

The role of computational chemistry in understanding the behavior of 2,5-Difluoro-4-nitrophenol cannot be overstated. Advanced computational methods allow researchers to predict molecular interactions, optimize synthetic pathways, and assess potential toxicity profiles before experimental validation. These tools are particularly valuable in drug discovery pipelines where rapid screening of large libraries of compounds is essential. By integrating computational predictions with experimental data, scientists can accelerate the development process while ensuring safety and efficacy.

In conclusion, 2,5-Difluoro-4-nitrophenol, identified by CAS No 120103-18-6, represents a significant compound in modern chemical research with applications spanning synthetic chemistry and pharmaceutical development. Its unique structural features make it an invaluable intermediate for creating novel bioactive molecules with potential therapeutic benefits. As research continues to uncover new applications for this compound, its importance in advancing medicinal chemistry is likely to grow further.

• 179816-26-3(2-Fluoro-3-nitrophenol)
• 66684-59-1(2,3-Difluoro-4-nitroanisole)
• 403-19-0(2-Fluoro-4-nitrophenol)
• 2105-96-6(4-Fluoro-3-nitrophenol)
• 22510-08-3(2-Fluoro-5-nitrophenol)
• 21571-34-6(Phenol,2-fluoro-4-nitro-, potassium salt (1:1))
• 113512-57-5(2,4-Difluoro-5-nitrophenol)
• 394-41-2(3-Fluoro-4-nitrophenol)
• 658-07-1(2,6-Difluoro-4-nitrophenol)
• 445-68-1(2-fluoro-1-methoxy-3-nitrobenzene)